Skip to main content

IT Matters: The Erectile Restoration Registry

Enrolling by invitation · NCT04200937

Conditions: Erectile Dysfunction

At a glance

Research payments reported, 2025
$475,940
U.S. investigators named
22
Sites paid
23
Planned or actual enrollment
450

About the trial

Sponsor
Boston Scientific Corporation
Tested
Tactra Malleable (device), Spectra™ Concealable Penile Prothesis (device), AMS Ambicor™ Inflatable Penile Prosthesis (device), AMS 700™ Inflatable Penile Prosthesis w/Momentary Squeeze (MS) Pump (device), AMS 700™ Inflatable Penile Prosthesis w/Tenacio™ Pump (device)
Dates
Started 2021-08-05; completion 2031-12
Results posted
Not yet

The objective of the It MATTERS registry is to collect Real-World Data (RWD) to monitor the safe and effective use of commercially available Boston Scientific Corporation (BSC) penile prostheses

From ClinicalTrials.gov, last updated 2026-10-13. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Boston Scientific Corporation reported $475,940 in research payments for this study in 2025 (81 payments).

Products named: Tactra

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.